Evidence map›Paper›PMID 42850911›Full record

ArticleChemMedChem2026

Ti(IV) Asymmetric Acetyl-Substituted Phenolato Hexacoordinate Complexes as Anticancer Chemotherapy of Enhanced Bioavailability.

Mohammad Taha, Anwesh Pandey, Avital Shurki, Edit Y Tshuva

Abstract read
PubMed Publisher
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad TahaInstitute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel.ORCID https://orcid.org/0009-0008-6129-6075
Anwesh PandeyInstitute of Drug research, School of Pharmacy, The Hebrew University of Jerusalem, Ein Kerem Campus, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-6227-829X
Avital ShurkiInstitute of Drug research, School of Pharmacy, The Hebrew University of Jerusalem, Ein Kerem Campus, Jerusalem, Israel.
Edit Y TshuvaInstitute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel.ORCID https://orcid.org/0000-0001-7452-3611

Funding

Israel Science Foundation 2286/23PAZY Foundation 490-23
6 · The paper itself

Abstract

A series of four titanium(IV) complexes based on asymmetric diaminobis(phenolato)-bis(alkoxo) ligands with different substitutions and acetyl functional groups was synthesized and characterized. All complexes were analyzed by

Indexed as

Antineoplastic AgentsCoordination ComplexesPhenolsTitaniumBiological AvailabilityCell Line, TumorCell ProliferationCell SurvivalCrystallography, X-RayDose-Response Relationship, DrugDrug Screening Assays, AntitumorHT29 CellsHumansModels, MolecularMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsCoordination ComplexesPhenolsTitaniumcancercisplatincytotoxicityphenolato ligandstitanium

Identifiers

PMID42850911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.